# FDA Warning Letter: Biosensors Interventional Technologies Pte Ltd
> 2023-07-25 · OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality · `1a7909cf955ddb76`
## Letter
- **Company:** Biosensors Interventional Technologies Pte Ltd
- **Posted Date:** 2023-07-25
- **Letter Issue Date:** 2023-07-21
- **Issuing Office:** OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality
## Subject
Medical Device Reporting/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*